BICYCLE THERAPEUTICS PLC 8-K

What Happened

• Bicycle Therapeutics plc (BCYC) filed a Form 8-K on March 17, 2026 announcing its financial results for the quarter and year ended December 31, 2025 (press release furnished as Exhibit 99.1) and reporting a Board appointment.
• On March 11, 2026 the Board appointed Jennifer Perry, Pharm.D., as Chief Operating Officer, effective March 17, 2026. Dr. Perry succeeds Alistair Milnes, who becomes Chief Corporate Development Officer on the same date.

Key Details

• Dr. Jennifer Perry’s appointment effective date: March 17, 2026 (Board action on March 11, 2026).
• Compensation: base salary of $550,000 and eligibility for a target annual cash bonus equal to 50% of base salary.
• Severance: if terminated without cause or for good reason, nine months’ base salary and up to nine months’ COBRA; if termination occurs within 12 months after a change in control, 18 months’ base salary, up to 18 months’ COBRA, a lump-sum full annual bonus at target, and full acceleration of unvested equity awards.
• Additional: Dr. Perry is subject to the Company’s standard proprietary and non-solicitation agreement and an indemnity agreement under English & Welsh law; no related party or family relationships requiring Item 404 disclosure were reported. The full employment agreement will be filed in the Company’s 10-Q for the quarter ending March 31, 2026.

Why It Matters

• Leadership: appointing an experienced commercial and strategy executive as COO may affect commercialization and operational execution—important to watch for any changes in commercial plans or milestones.
• Financial impact: the disclosed salary, bonus target, and potential severance obligations are concrete elements of executive compensation that can affect cash burn and governance disclosures.
• Next steps for investors: review the March 17, 2026 press release (Exhibit 99.1) for the detailed earnings/financial results and business highlights, and check the upcoming 10-Q for the full employment agreement and any additional disclosures.